843 results on '"Kanetsky, Peter A."'
Search Results
2. Association of functional, inherited vitamin D-binding protein variants with melanoma-specific death.
- Author
-
Gallagher, Richard, Zanetti, Roberto, Rosso, Stefano, Sacchetto, Lidia, Edmiston, Sharon, Conway, Kathleen, Ollila, David, Begg, Colin, Berwick, Marianne, Ward, Sarah, Orlow, Irene, Gibbs, David, Thomas, Nancy, Kanetsky, Peter, Luo, Li, Busam, Klaus, Cust, Anne, and Anton-Culver, Hoda
- Subjects
Humans ,Vitamin D-Binding Protein ,Vitamin D ,Polymorphism ,Single Nucleotide ,Melanoma - Abstract
BACKGROUND: It is unclear whether genetic variants affecting vitamin D metabolism are associated with melanoma prognosis. Two functional missense variants in the vitamin D-binding protein gene (GC), rs7041 and rs4588, determine 3 common haplotypes, Gc1s, Gc1f, and Gc2, of which Gc1f may be associated with decreased all-cause death among melanoma patients based on results of a prior study, but the association of Gc1f with melanoma-specific death is unclear. METHODS: We investigated the association of the Gc1s, Gc1f, and Gc2 haplotypes with melanoma-specific and all-cause death among 4490 individuals with incident, invasive primary melanoma in 2 population-based studies using multivariable Cox-proportional hazards regression. RESULTS: In the pooled analysis of both datasets, the patients with the Gc1f haplotype had a 37% lower risk of melanoma-specific death than the patients without Gc1f (hazard ratio [HR] = 0.63, 95% confidence interval [CI] = 0.47 to 0.83, P = .001), with adjustments for age, sex, study center, first- or higher-order primary melanoma, tumor site, pigmentary phenotypes, and Breslow thickness. Associations were similar in both studies. In pooled analyses stratified by Breslow thickness, the corresponding melanoma-specific death HRs for those patients with the Gc1f haplotype compared with those without Gc1f were 0.89 (95% CI = 0.63 to 1.27) among participants with tumor Breslow thickness equal to or less than 2.0 mm and 0.40 (95% CI = 0.25 to 0.63) among participants with tumor Breslow thickness greater than 2.0 mm (Pinteraction = .003). CONCLUSIONS: Our findings suggest that individuals with the GC haplotype Gc1f may have a lower risk of dying from melanoma-specifically from thicker, higher-risk melanoma-than individuals without this Gc1f haplotype.
- Published
- 2023
3. Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions
- Author
-
Lindström, Sara, Wang, Lu, Feng, Helian, Majumdar, Arunabha, Huo, Sijia, Macdonald, James, Harrison, Tabitha, Turman, Constance, Chen, Hongjie, Mancuso, Nicholas, Bammler, Theo, Consortium, Breast Cancer Association, Gallinger, Steve, Gruber, Stephen B, Gunter, Marc J, Le Marchand, Loic, Moreno, Victor, Offit, Kenneth, Study, Genetics And Epidemiology Of Colorectal Cancer Consortium Colorectal Transdisciplinary Study Colon Cancer Family Registry, De Vivo, Immaculata, O’Mara, Tracy A, Spurdle, Amanda B, Tomlinson, Ian, Consortium, Endometrial Cancer Association, Fitzgerald, Rebecca, Gharahkhani, Puya, Gockel, Ines, Jankowski, Janusz, Macgregor, Stuart, Schumacher, Johannes, Barnholtz-Sloan, Jill, Bondy, Melissa L, Houlston, Richard S, Jenkins, Robert B, Melin, Beatrice, Wrensch, Margaret, Brennan, Paul, Christiani, David C, Johansson, Mattias, Mckay, James, Aldrich, Melinda C, Amos, Christopher I, Landi, Maria Teresa, Tardon, Adonina, Consortium, International Lung Cancer, Bishop, D Timothy, Demenais, Florence, Goldstein, Alisa M, Iles, Mark M, Kanetsky, Peter A, Law, Matthew H, Consortium, Ovarian Cancer Association, Amundadottir, Laufey T, Stolzenberg-Solomon, Rachael, Wolpin, Brian M, Consortium, Pancreatic Cancer Cohort, Klein, Alison, Petersen, Gloria, Risch, Harvey, Consortium, The PRACTICAL Consortium Pancreatic Cancer Case-Control, Chanock, Stephen J, Purdue, Mark P, Scelo, Ghislaine, Pharoah, Paul, Kar, Siddhartha, Hung, Rayjean J, Pasaniuc, Bogdan, and Kraft, Peter
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Human Genome ,Genetics ,Digestive Diseases ,Prevention ,Clinical Research ,Urologic Diseases ,Cancer ,Rare Diseases ,Aetiology ,2.1 Biological and endogenous factors ,Male ,Humans ,Genome-Wide Association Study ,Genetic Predisposition to Disease ,Neoplasms ,Risk Factors ,Transcriptome ,Polymorphism ,Single Nucleotide ,Breast Cancer Association Consortium ,Colorectal Transdisciplinary Study (CORECT) ,Colon Cancer Family Registry Study (CCFR) ,Genetics And Epidemiology Of Colorectal Cancer Consortium ,Endometrial Cancer Association Consortium ,International Lung Cancer Consortium ,Ovarian Cancer Association Consortium ,Pancreatic Cancer Cohort Consortium ,Pancreatic Cancer Case-Control Consortium (Panc4) ,The PRACTICAL Consortium ,Oncology & Carcinogenesis ,Oncology and carcinogenesis - Abstract
BackgroundThe shared inherited genetic contribution to risk of different cancers is not fully known. In this study, we leverage results from 12 cancer genome-wide association studies (GWAS) to quantify pairwise genome-wide genetic correlations across cancers and identify novel cancer susceptibility loci.MethodsWe collected GWAS summary statistics for 12 solid cancers based on 376 759 participants with cancer and 532 864 participants without cancer of European ancestry. The included cancer types were breast, colorectal, endometrial, esophageal, glioma, head and neck, lung, melanoma, ovarian, pancreatic, prostate, and renal cancers. We conducted cross-cancer GWAS and transcriptome-wide association studies to discover novel cancer susceptibility loci. Finally, we assessed the extent of variant-specific pleiotropy among cancers at known and newly identified cancer susceptibility loci.ResultsWe observed widespread but modest genome-wide genetic correlations across cancers. In cross-cancer GWAS and transcriptome-wide association studies, we identified 15 novel cancer susceptibility loci. Additionally, we identified multiple variants at 77 distinct loci with strong evidence of being associated with at least 2 cancer types by testing for pleiotropy at known cancer susceptibility loci.ConclusionsOverall, these results suggest that some genetic risk variants are shared among cancers, though much of cancer heritability is cancer-specific and thus tissue-specific. The increase in statistical power associated with larger sample sizes in cross-disease analysis allows for the identification of novel susceptibility regions. Future studies incorporating data on multiple cancer types are likely to identify additional regions associated with the risk of multiple cancer types.
- Published
- 2023
4. Sex-Specific Associations of MDM2 and MDM4 Variants with Risk of Multiple Primary Melanomas and Melanoma Survival in Non-Hispanic Whites
- Author
-
Ward, Sarah V, Autuori, Isidora, Luo, Li, LaPilla, Emily, Yoo, Sarah, Sharma, Ajay, Busam, Klaus J, Olilla, David W, Dwyer, Terence, Anton-Culver, Hoda, Zanetti, Roberto, Sacchetto, Lidia, Cust, Anne E, Gallagher, Richard P, Kanetsky, Peter A, Rosso, Stefano, Begg, Colin B, Berwick, Marianne, Thomas, Nancy E, and Orlow, Irene
- Subjects
Genetics ,Cancer ,Prevention ,MDM2 ,MDM4 ,melanoma ,gene ,polymorphism ,risk ,survival ,sex ,functional ,estrogen-receptor ,GEM Study Group ,Oncology and Carcinogenesis - Abstract
MDM2-SNP309 (rs2279744), a common genetic modifier of cancer incidence in Li-Fraumeni syndrome, modifies risk, age of onset, or prognosis in a variety of cancers. Melanoma incidence and outcomes vary by sex, and although SNP309 exerts an effect on the estrogen receptor, no consensus exists on its effect on melanoma. MDM2 and MDM4 restrain p53-mediated tumor suppression, independently or together. We investigated SNP309, an a priori MDM4-rs4245739, and two coinherited variants, in a population-based cohort of 3663 primary incident melanomas. Per-allele and per-haplotype (MDM2_SNP309-SNP285; MDM4_rs4245739-rs1563828) odds ratios (OR) for multiple-melanoma were estimated with logistic regression models. Hazard ratios (HR) for melanoma death were estimated with Cox proportional hazards models. In analyses adjusted for covariates, females carrying MDM4-rs4245739*C were more likely to develop multiple melanomas (ORper-allele = 1.25, 95% CI 1.03-1.51, and Ptrend = 0.03), while MDM2-rs2279744*G was inversely associated with melanoma-death (HRper-allele = 0.63, 95% CI 0.42-0.95, and Ptrend = 0.03). We identified 16 coinherited expression quantitative loci that control the expression of MDM2, MDM4, and other genes in the skin, brain, and lungs. Our results suggest that MDM4/MDM2 variants are associated with the development of subsequent primaries and with the death of melanoma in a sex-dependent manner. Further investigations of the complex MDM2/MDM4 motif, and its contribution to the tumor microenvironment and observed associations, are warranted.
- Published
- 2023
5. Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma
- Author
-
Yardman-Frank, Joseph Michael, Bronner, Baillie, Rosso, Stefano, From, Lynn, Busam, Klaus, Groben, Pam, Tucker, Paul, Cust, Anne, Armstrong, Bruce, Kricker, Anne, Marrett, Loraine, Anton-Culver, Hoda, Gruber, Stephen, Gallagher, Rick, Zanetti, Roberto, Sacchetto, Lidia, Dwyer, Terry, Venn, Alison, Orlow, Irene, Kanetsky, Peter, Luo, Li, Thomas, Nancy, Begg, Colin, Berwick, Marianne, Team, GEM Study, Busam, Klaus J, Autuori, Isidora, Roy, Pampa, Reiner, Anne, Boyce, Tawny W, Cust, Anne E, Armstrong, Bruce K, Dwyer, Terence, Gallagher, Richard P, Marrett, Loraine D, Gruber, Stephen B, Bonner, Joseph D, Thomas, Nancy E, Conway, Kathleen, Ollila, David W, Groben, Pamela A, Edmiston, Sharon N, Hao, Honglin, Parrish, Eloise, Frank, Jill S, Gibbs, David C, Rebbeck, Timothy R, Kanetsky, Peter A, Taylor, Julia Lee, and Madronich, Sasha
- Subjects
Data Management and Data Science ,Information and Computing Sciences ,Biomedical and Clinical Sciences ,GEM Study Team - Published
- 2021
6. Skin cancer prevention behaviors, beliefs, distress, and worry among hispanics in Florida and Puerto Rico
- Author
-
Lacson, John Charles A., Soto-Torres, Brenda, Sutton, Steven K., Doyle, Scarlet H., Kim, Youngchul, Roetzheim, Richard G., Vadaparampil, Susan T., and Kanetsky, Peter A.
- Published
- 2023
- Full Text
- View/download PDF
7. Associations between social COVID-19 exposure and psychological functioning
- Author
-
Lewicka, Malwina, Hamilton, Jada G., Waters, Erika A., Orom, Heather, Schofield, Elizabeth, Kiviniemi, Marc T., and Kanetsky, Peter A.
- Subjects
Epidemics -- Influence -- Psychological aspects -- Social aspects ,Mental health -- Evaluation ,Psychology and mental health - Abstract
The negative consequences of the COVID-19 pandemic on mental health have been widely reported, but less is known about how the impact of COVID-19 on others in one's social circle shapes these high distress levels. This study examines associations between social COVID-19 exposure-knowing someone who had a COVID-19 infection-and psychological functioning, as well as whether socio-demographic factors moderate these relationships. In June 2020, respondents (N = 343) from clinics in Tampa, Florida, U.S.A. reported whether they had social COVID-19 exposure, anxiety, depression, and stress, and other COVID-19-related concerns. Social COVID-19 exposure was associated with increased anxiety, stress, and concerns about a family member getting sick, and concerns about drinking and substance use. Several associations between exposure and psychological functioning were stronger in women, younger people, and people with lower income, implying these groups face elevated psychological risks due to the pandemic, and should be prioritized in mental health recovery efforts., Author(s): Malwina Lewicka [sup.1] , Jada G. Hamilton [sup.1] , Erika A. Waters [sup.2] , Heather Orom [sup.3] , Elizabeth Schofield [sup.1] , Marc T. Kiviniemi [sup.4] , Peter A. [...]
- Published
- 2023
- Full Text
- View/download PDF
8. Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes
- Author
-
Pyle, Louise C., Kim, Jung, Bradfield, Jonathan, Damrauer, Scott M., D'Andrea, Kurt, Einhorn, Lawrence H., Godse, Rama, Hakonarson, Hakon, Kanetsky, Peter A., Kember, Rachel L., Jacobs, Linda A., Maxwell, Kara N., Rader, Daniel J., Vaughn, David J., Weathers, Benita, Wubbenhorst, Bradley, Regeneron Genetics Center Research Team, Cancer Genomics Research Laboratory, Greene, Mark H., Nathanson, Katherine L., and Stewart, Douglas R.
- Published
- 2024
- Full Text
- View/download PDF
9. Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study
- Author
-
Davari, Danielle R, Orlow, Irene, Kanetsky, Peter A, Luo, Li, Edmiston, Sharon N, Conway, Kathleen, Parrish, Eloise A, Hao, Honglin, Busam, Klaus J, Sharma, Ajay, Kricker, Anne, Cust, Anne E, Anton-Culver, Hoda, Gruber, Stephen B, Gallagher, Richard P, Zanetti, Roberto, Rosso, Stefano, Sacchetto, Lidia, Dwyer, Terence, Ollila, David W, Begg, Colin B, Berwick, Marianne, Thomas, Nancy E, and Group, on behalf of the GEM Study
- Subjects
Clinical Research ,Human Genome ,Cardiovascular ,Cancer ,Genetics ,Diabetes ,Heart Disease ,Heart Disease - Coronary Heart Disease ,Aged ,Cyclin-Dependent Kinase Inhibitor p15 ,Female ,GTP Phosphohydrolases ,Genome-Wide Association Study ,Humans ,Lymphocytes ,Tumor-Infiltrating ,Male ,Melanoma ,Membrane Proteins ,Middle Aged ,Mutation ,Proto-Oncogene Proteins B-raf ,Skin Neoplasms ,coronary artery disease ,coronary artery calci fi cation ,myocardial ,GEM Study Group ,Medical and Health Sciences ,Epidemiology - Abstract
BackgroundGenome-wide association studies have reported that genetic variation at ANRIL (CDKN2B-AS1) is associated with risk of several chronic diseases including coronary artery disease, coronary artery calcification, myocardial infarction, and type 2 diabetes mellitus. ANRIL is located at the CDKN2A/B locus, which encodes multiple melanoma tumor suppressors. We investigated the association of these variants with melanoma prognostic characteristics.MethodsThe Genes, Environment, and Melanoma Study enrolled 3,285 European origin participants with incident invasive primary melanoma. For each of ten disease-associated SNPs at or near ANRIL, we used linear and logistic regression modeling to estimate, respectively, the per allele mean changes in log of Breslow thickness and ORs for presence of ulceration and tumor-infiltrating lymphocytes (TIL). We also assessed effect modification by tumor NRAS/BRAF mutational status.ResultsRs518394, rs10965215, and rs564398 passed false discovery and were each associated (P ≤ 0.005) with TILs, although only rs564398 was independently associated (P = 0.0005) with TILs. Stratified by NRAS/BRAF mutational status, rs564398*A was significantly positively associated with TILs among NRAS/BRAF mutant, but not wild-type, cases. We did not find SNP associations with Breslow thickness or ulceration.ConclusionsANRIL rs564398 was associated with TIL presence in primary melanomas, and this association may be limited to NRAS/BRAF-mutant cases.ImpactPathways related to ANRIL variants warrant exploration in relationship to TILs in melanoma, especially given the impact of TILs on immunotherapy and survival.
- Published
- 2021
10. Sharing and seeking information about skin cancer risk and prevention among Hispanic people from Florida and Puerto Rico
- Author
-
Rivera Rivera, Jessica N., Lacson, John Charles A., Kim, Youngchul, Roetzheim, Richard G., Sutton, Steven K., Soto-Torres, Brenda, Vadaparampil, Susan T., and Kanetsky, Peter A.
- Published
- 2023
- Full Text
- View/download PDF
11. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
- Author
-
Newson, Ainsley J., Morton, Rachael L., Kimlin, Michael, Keogh, Louise, Law, Matthew, Kirk, Judy, Dobbinson, Suzanne J., Kanetsky, Peter, Mann, Graham, Dawkins, Hugh, Savard, Jacqueline, Dunlop, Kate, Trevena, Lyndal, Jenkins, Mark, Allen, Martin, Butow, Phyllis, Wordsworth, Sarah, Lo, Serigne, Low, Cynthia, Smit, Amelia K., Espinoza, David, Cust, Anne E., Law, Chi Kin, Fernandez-Penas, Pablo, Nieweg, Omgo E., and Menzies, Alexander M.
- Published
- 2023
- Full Text
- View/download PDF
12. Predictors of correct recall of genetic risk information among Hispanic individuals in Florida and Puerto Rico
- Author
-
Lacson, John Charles A., Sutton, Steven K., Kim, Youngchul, Roetzheim, Richard G., Vadaparampil, Susan T., Soto-Torres, Brenda, and Kanetsky, Peter A.
- Published
- 2023
- Full Text
- View/download PDF
13. Differences in Melanoma Between Canada and New South Wales, Australia: A Population-Based Genes, Environment, and Melanoma (GEM) Study
- Author
-
Yardman-Frank, Joseph Michael, Glassheim, Elyssa, Kricker, Anne, Armstrong, Bruce K, Marrett, Loraine D, Luo, Li, Cust, Anne E, Busam, Klaus J, Orlow, Irene, Gallagher, Richard P, Gruber, Stephen B, Anton-Culver, Hoda, Rosso, Stefano, Zanetti, Roberto, Sacchetto, Lidia, Kanetsky, Peter A, Dwyer, Terence, Venn, Alison, Lee-Taylor, Julia, Begg, Colin B, Thomas, Nancy E, and Berwick, Marianne
- Subjects
Climate Change Impacts and Adaptation ,Biomedical and Clinical Sciences ,Environmental Sciences ,Health Sciences ,Cancer - Abstract
In an effort to understand the difference between melanomas diagnosed in Australia (New South Wales) and Canada, where the incidence in New South Wales is almost three times greater than in Canada, and mortality is twice as high although survival is slightly more favorable, we had one pathologist review 1,271 melanomas from British Columbia and Ontario, Canada, to compare these to melanomas in New South Wales, Australia. We hypothesized that histopathologic characteristics might provide insight into divergent pathways to melanoma development. We found a number of differences in risk factors and tumor characteristics between the two geographic areas. There were higher mole counts and darker phenotypes in the Canadian patients, while the Australian patients had greater solar elastosis, more lentigo maligna melanomas, and more tumor infiltrating lymphocytes. We hypothesize that the differences observed may illustrate different etiologies – the cumulative exposure pathway among Australian patients and the nevus pathway among Canadian patients. This is one of the largest studies investigating the divergent pathway hypothesis and is particularly robust due to the evaluation of all lesions by one dermatopathologist.
- Published
- 2021
14. Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study
- Author
-
Davari, Danielle R, Orlow, Irene, Kanetsky, Peter A, Luo, Li, Busam, Klaus J, Sharma, Ajay, Kricker, Anne, Cust, Anne E, Anton-Culver, Hoda, Gruber, Stephen B, Gallagher, Richard P, Zanetti, Roberto, Rosso, Stefano, Sacchetto, Lidia, Dwyer, Terence, Gibbs, David C, Ollila, David W, Begg, Colin B, Berwick, Marianne, and Thomas, Nancy E
- Subjects
Genetics ,Clinical Research ,Human Genome ,Cancer ,Aetiology ,2.1 Biological and endogenous factors ,Genome-Wide Association Study ,Humans ,Lymphocytes ,Tumor-Infiltrating ,Melanoma ,Prognosis ,Skin Neoplasms ,melanoma ,single nucleotide polymorphism ,Breslow thickness ,ulceration ,mitoses ,tumor-infiltrating lymphocytes ,survival ,Oncology and Carcinogenesis ,Oncology & Carcinogenesis - Abstract
Genome-wide association studies (GWAS) and candidate pathway studies have identified low-penetrant genetic variants associated with cutaneous melanoma. We investigated the association of melanoma-risk variants with primary melanoma tumor prognostic characteristics and melanoma-specific survival. The Genes, Environment, and Melanoma Study enrolled 3285 European origin participants with incident invasive primary melanoma. For each of 47 melanoma-risk single nucleotide polymorphisms (SNPs), we used linear and logistic regression modeling to estimate, respectively, the per allele mean changes in log of Breslow thickness and odds ratios for presence of ulceration, mitoses, and tumor-infiltrating lymphocytes (TILs). We also used Cox proportional hazards regression modeling to estimate the per allele hazard ratios for melanoma-specific survival. Passing the false discovery threshold (p = 0.0026) were associations of IRF4 rs12203592 and CCND1 rs1485993 with log of Breslow thickness, and association of TERT rs2242652 with presence of mitoses. IRF4 rs12203592 also had nominal associations (p < 0.05) with presence of mitoses and melanoma-specific survival, as well as a borderline association (p = 0.07) with ulceration. CCND1 rs1485993 also had a borderline association with presence of mitoses (p = 0.06). MX2 rs45430 had nominal associations with log of Breslow thickness, presence of mitoses, and melanoma-specific survival. Our study indicates that further research investigating the associations of these genetic variants with underlying biologic pathways related to tumor progression is warranted.
- Published
- 2021
15. Association of Known Melanoma Risk Factors with Primary Melanoma of the Scalp and Neck
- Author
-
Wood, Renee P, Heyworth, Jane S, McCarthy, Nina S, Mauguen, Audrey, Berwick, Marianne, Thomas, Nancy E, Millward, Michael J, Anton-Culver, Hoda, Cust, Anne E, Dwyer, Terence, Gallagher, Richard P, Gruber, Stephen B, Kanetsky, Peter A, Orlow, Irene, Rosso, Stefano, Moses, Eric K, Begg, Colin B, and Ward, Sarah V
- Subjects
Biomedical and Clinical Sciences ,Health Sciences ,Oncology and Carcinogenesis ,Dental/Oral and Craniofacial Disease ,Clinical Trials and Supportive Activities ,Cancer ,Clinical Research ,Aged ,Female ,Humans ,Male ,Melanoma ,Middle Aged ,Neck ,Risk Factors ,Scalp ,Skin Neoplasms ,Medical and Health Sciences ,Epidemiology ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundScalp and neck (SN) melanoma confers a worse prognosis than melanoma of other sites but little is known about its determinants. We aimed to identify associations between SN melanoma and known risk genes, phenotypic traits, and sun exposure patterns.MethodsParticipants were cases from the Western Australian Melanoma Health Study (n = 1,200) and the Genes, Environment, and Melanoma Study (n = 3,280). Associations between risk factors and SN melanoma, compared with truncal and arm/leg melanoma, were investigated using binomial logistic regression. Facial melanoma was also compared with the trunk and extremities, to evaluate whether associations were subregion specific, or reflective of the whole head/neck region.ResultsCompared with other sites, increased odds of SN and facial melanoma were observed in older individuals [SN: OR = 1.28, 95% confidence interval (CI) = 0.92-1.80, P trend = 0.016; Face: OR = 4.57, 95% CI = 3.34-6.35, P trend < 0.001] and those carrying IRF4-rs12203592*T (SN: OR = 1.35, 95% CI = 1.12-1.63, P trend = 0.002; Face: OR = 1.29, 95% CI = 1.10-1.50, P trend = 0.001). Decreased odds were observed for females (SN: OR = 0.49, 95% CI = 0.37-0.64, P < 0.001; Face: OR = 0.66, 95% CI = 0.53-0.82, P < 0.001) and the presence of nevi (SN: OR = 0.66, 95% CI = 0.49-0.89, P = 0.006; Face: OR = 0.65, 95% CI = 0.52-0.83, P < 0.001).ConclusionsDifferences observed between SN melanoma and other sites were also observed for facial melanoma. Factors previously associated with the broader head and neck region, notably older age, may be driven by the facial subregion. A novel finding was the association of IRF4-rs12203592 with both SN and facial melanoma.ImpactUnderstanding the epidemiology of site-specific melanoma will enable tailored strategies for risk factor reduction and site-specific screening campaigns.
- Published
- 2020
16. Piloting the Sexual and Gender Minority Cancer Curricular Advances for Research and Education (SGM Cancer CARE) Workshop: Research Training in the Service of SGM Cancer Health Equity
- Author
-
Kano, Miria, Tamí-Maury, Irene, Pratt-Chapman, Mandi L., Chang, Shine, Kosich, Mikaela, Quinn, Gwendolyn P., Poteat, Tonia, Kanetsky, Peter A., Elk, Ronit, Boehmer, Ulrike, Sanchez, Julian, Kamen, Charles, and Sanchez, Nelson F.
- Published
- 2022
- Full Text
- View/download PDF
17. Qualitative assessment of uptake retention and evaluation of prevention materials for skin cancer among Hispanics
- Author
-
Crowder, Sylvia L., Buro, Acadia W., Lacson, John Charles A., Del Rio, Jocelyn, Kim, Youngchul, Roetzheim, Richard G., Sutton, Steven K., Vadaparampil, Susan T., Soto-Torres, Brenda, Stern, Marilyn, and Kanetsky, Peter A.
- Published
- 2023
- Full Text
- View/download PDF
18. The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma.
- Author
-
Wang, Xuefeng, Yu, Xiaoqing, Krauthammer, Michael, Hugo, Willy, Duan, Chunzhe, Kanetsky, Peter, Teer, Jamie, Thompson, Zachary, Kalos, Denise, Tsai, Kenneth, Smalley, Keiran, Sondak, Vernon, Chen, Y, and Conejo-Garcia, Jose
- Subjects
Biomarkers ,Tumor ,CA-125 Antigen ,Female ,Humans ,Male ,Melanoma ,Membrane Proteins ,Mutation ,Prognosis ,Skin Neoplasms ,Survival Analysis - Abstract
BACKGROUND: MUC16 is a mucin marker that is frequently mutated in melanoma, but whether MUC16 mutations could be useful as a surrogate biomarker for tumor mutation burden (TMB) remains unclear. METHODS: This study rigorously evaluates the MUC16 mutation as a clinical biomarker in cutaneous melanoma by utilizing genomic and clinical data from patient samples from The Cancer Genome Atlas (TCGA) and two independent validation cohorts. We further extended the analysis to studies with patients treated with immunotherapies. RESULTS: Analysis results showed that samples with MUC16 mutations had a higher TMB than the samples of wild-type, with strong statistical significance (P < 0.001) in all melanoma cohorts tested. Associations between MUC16 mutations and TMB remained statistically significant after adjusting for potential confounding factors in the TCGA cohort [OR, 9.28 (95% confidence interval (CI), 5.18-17.39); P < 0.001], Moffitt cohort [OR, 31.95 (95% CI, 8.71-163.90); P < 0.001], and Yale cohort [OR, 8.09 (95% CI, 3.12-23.79); P < 0.01]. MUC16 mutations were also found to be associated with overall survival in the TCGA [HR, 0.62; (95% CI, 0.45-0.85); P < 0.01] and Moffitt cohorts [HR, 0.49 (95% CI, 0.28-0.87); P = 0.014]. Strikingly, MUC16 is the only top frequently mutated gene for which prognostic significance was observed. MUC16 mutations were also found valuable in predicting anti-CTLA-4 and anti-PD-1 therapy responses. CONCLUSIONS: MUC16 mutation appears to be a useful predictive marker of global TMB and patient survival in melanoma. IMPACT: This is, to the best of our knowledge, the first systematic evaluation of MUC16 mutation as a clinical biomarker and a predictive biomarker for immunotherapy in melanoma.
- Published
- 2020
19. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.
- Author
-
Zhang, Yan Dora, Hurson, Amber N, Zhang, Haoyu, Choudhury, Parichoy Pal, Easton, Douglas F, Milne, Roger L, Simard, Jacques, Hall, Per, Michailidou, Kyriaki, Dennis, Joe, Schmidt, Marjanka K, Chang-Claude, Jenny, Gharahkhani, Puya, Whiteman, David, Campbell, Peter T, Hoffmeister, Michael, Jenkins, Mark, Peters, Ulrike, Hsu, Li, Gruber, Stephen B, Casey, Graham, Schmit, Stephanie L, O'Mara, Tracy A, Spurdle, Amanda B, Thompson, Deborah J, Tomlinson, Ian, De Vivo, Immaculata, Landi, Maria Teresa, Law, Matthew H, Iles, Mark M, Demenais, Florence, Kumar, Rajiv, MacGregor, Stuart, Bishop, D Timothy, Ward, Sarah V, Bondy, Melissa L, Houlston, Richard, Wiencke, John K, Melin, Beatrice, Barnholtz-Sloan, Jill, Kinnersley, Ben, Wrensch, Margaret R, Amos, Christopher I, Hung, Rayjean J, Brennan, Paul, McKay, James, Caporaso, Neil E, Berndt, Sonja I, Birmann, Brenda M, Camp, Nicola J, Kraft, Peter, Rothman, Nathaniel, Slager, Susan L, Berchuck, Andrew, Pharoah, Paul DP, Sellers, Thomas A, Gayther, Simon A, Pearce, Celeste L, Goode, Ellen L, Schildkraut, Joellen M, Moysich, Kirsten B, Amundadottir, Laufey T, Jacobs, Eric J, Klein, Alison P, Petersen, Gloria M, Risch, Harvey A, Stolzenberg-Solomon, Rachel Z, Wolpin, Brian M, Li, Donghui, Eeles, Rosalind A, Haiman, Christopher A, Kote-Jarai, Zsofia, Schumacher, Fredrick R, Al Olama, Ali Amin, Purdue, Mark P, Scelo, Ghislaine, Dalgaard, Marlene D, Greene, Mark H, Grotmol, Tom, Kanetsky, Peter A, McGlynn, Katherine A, Nathanson, Katherine L, Turnbull, Clare, Wiklund, Fredrik, Breast Cancer Association Consortium (BCAC), Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON), Colon Cancer Family Registry (CCFR), Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT), Endometrial Cancer Association Consortium (ECAC), Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Melanoma Genetics Consortium (GenoMEL), Glioma International Case-Control Study (GICC), International Lung Cancer Consortium (ILCCO), Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium, International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph), Ovarian Cancer Association Consortium (OCAC), Oral Cancer GWAS, Pancreatic Cancer Case-Control Consortium (PanC4), Pancreatic Cancer Cohort Consortium (PanScan), and Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)
- Subjects
Breast Cancer Association Consortium ,Barrett’s and Esophageal Adenocarcinoma Consortium ,Colon Cancer Family Registry ,Transdisciplinary Studies of Genetic Variation in Colorectal Cancer ,Endometrial Cancer Association Consortium ,Genetics and Epidemiology of Colorectal Cancer Consortium ,Melanoma Genetics Consortium ,Glioma International Case-Control Study ,International Lung Cancer Consortium ,Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium ,International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies ,Ovarian Cancer Association Consortium ,Oral Cancer GWAS ,Pancreatic Cancer Case-Control Consortium ,Pancreatic Cancer Cohort Consortium ,Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome ,Renal Cancer GWAS ,Testicular Cancer Consortium ,Animals ,Humans ,Neoplasms ,Genetic Predisposition to Disease ,Incidence ,Risk Assessment ,Risk Factors ,Multifactorial Inheritance ,Polymorphism ,Single Nucleotide ,Models ,Genetic ,Female ,Male ,Genome-Wide Association Study ,Human Genome ,Prevention ,Cancer ,Prostate Cancer ,Genetics ,Urologic Diseases ,2.1 Biological and endogenous factors - Abstract
Genome-wide association studies (GWAS) have led to the identification of hundreds of susceptibility loci across cancers, but the impact of further studies remains uncertain. Here we analyse summary-level data from GWAS of European ancestry across fourteen cancer sites to estimate the number of common susceptibility variants (polygenicity) and underlying effect-size distribution. All cancers show a high degree of polygenicity, involving at a minimum of thousands of loci. We project that sample sizes required to explain 80% of GWAS heritability vary from 60,000 cases for testicular to over 1,000,000 cases for lung cancer. The maximum relative risk achievable for subjects at the 99th risk percentile of underlying polygenic risk scores (PRS), compared to average risk, ranges from 12 for testicular to 2.5 for ovarian cancer. We show that PRS have potential for risk stratification for cancers of breast, colon and prostate, but less so for others because of modest heritability and lower incidence.
- Published
- 2020
20. Predictors of genetic risk recall among the participants of a randomized controlled precision prevention trial against melanoma
- Author
-
Lacson, John Charles A., Kim, Youngchul, Roetzheim, Richard G., Sutton, Steven K., Vadaparampil, Susan T., and Kanetsky, Peter A.
- Published
- 2023
- Full Text
- View/download PDF
21. MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
- Author
-
Pellegrini, Cristina, Botta, Francesca, Massi, Daniela, Martorelli, Claudia, Facchetti, Fabio, Gandini, Sara, Maisonneuve, Patrick, Avril, Marie-Françoise, Demenais, Florence, Paillerets, Brigitte Bressac-de, Hoiom, Veronica, Cust, Anne E, Anton-Culver, Hoda, Gruber, Stephen B, Gallagher, Richard P, Marrett, Loraine, Zanetti, Roberto, Dwyer, Terence, Thomas, Nancy E, Begg, Colin B, Berwick, Marianne, Puig, Susana, Potrony, Miriam, Nagore, Eduardo, Ghiorzo, Paola, Menin, Chiara, Manganoni, Ausilia Maria, Rodolfo, Monica, Brugnara, Sonia, Passoni, Emanuela, Sekulovic, Lidija Kandolf, Baldini, Federica, Guida, Gabriella, Stratigos, Alexandros, Ozdemir, Fezal, Ayala, Fabrizio, Fernandez-de-Misa, Ricardo, Quaglino, Pietro, Ribas, Gloria, Romanini, Antonella, Migliano, Emilia, Stanganelli, Ignazio, Kanetsky, Peter A, Pizzichetta, Maria Antonietta, García-Borrón, Jose Carlos, Nan, Hongmei, Landi, Maria Teresa, Little, Julian, Newton-Bishop, Julia, Sera, Francesco, Fargnoli, Maria Concetta, Raimondi, Sara, Group, IMI Study, Alaibac, Mauro, Ferrari, Andrea, Valeri, Barbara, Sicher, Mariacristina, Mangiola, Daniela, Nazzaro, Gianluca, Tosti, Giulio, Mazzarol, Giovanni, Giudice, Giuseppe, Ribero, Simone, Astrua, Chiara, Mazzoni, Laura, Group, GEM Study, Orlow, Irene, Mujumdar, Urvi, Hummer, Amanda, Busam, Klaus, Roy, Pampa, Canchola, Rebecca, Clas, Brian, Cotignola, Javiar, Monroe, Yvette, Armstrong, Bruce, Kricker, Anne, Litchfield, Melisa, Tucker, Paul, Stephens, Nicola, Switzer, Teresa, Theis, Beth, From, Lynn, Chowdhury, Noori, Vanasse, Louise, Purdue, Mark, Northrup, David, Rosso, Stefano, Sacerdote, Carlotta, Leighton, Nancy, Gildea, Maureen, Bonner, Joe, Jeter, Joanne, Klotz, Judith, Wilcox, Homer, Weiss, Helen, Millikan, Robert, Mattingly, Dianne, and Player, Jon
- Subjects
Clinical Research ,Pediatric ,Genetics ,Prevention ,Cancer ,Adolescent ,Adult ,Aged ,Biomarkers ,Tumor ,Case-Control Studies ,Child ,Female ,Genetic Predisposition to Disease ,Germ-Line Mutation ,Humans ,Logistic Models ,Male ,Melanoma ,Middle Aged ,Odds Ratio ,Polymorphism ,Genetic ,Receptor ,Melanocortin ,Type 1 ,Retrospective Studies ,Skin Neoplasms ,IMI Study Group ,GEM Study Group ,M-SKIP Study Group - Abstract
BackgroundGermline variants in the melanocortin 1 receptor gene (MC1R) might increase the risk of childhood and adolescent melanoma, but a clear conclusion is challenging because of the low number of studies and cases. We assessed the association of MC1R variants with childhood and adolescent melanoma in a large study comparing the prevalence of MC1R variants in child or adolescent patients with melanoma to that in adult patients with melanoma and in healthy adult controls.MethodsIn this retrospective pooled analysis, we used the M-SKIP Project, the Italian Melanoma Intergroup, and other European groups (with participants from Australia, Canada, France, Greece, Italy, the Netherlands, Serbia, Spain, Sweden, Turkey, and the USA) to assemble an international multicentre cohort. We gathered phenotypic and genetic data from children or adolescents diagnosed with sporadic single-primary cutaneous melanoma at age 20 years or younger, adult patients with sporadic single-primary cutaneous melanoma diagnosed at age 35 years or older, and healthy adult individuals as controls. We calculated odds ratios (ORs) for childhood and adolescent melanoma associated with MC1R variants by multivariable logistic regression. Subgroup analysis was done for children aged 18 or younger and 14 years or younger.FindingsWe analysed data from 233 young patients, 932 adult patients, and 932 healthy adult controls. Children and adolescents had higher odds of carrying MC1R r variants than did adult patients (OR 1·54, 95% CI 1·02-2·33), including when analysis was restricted to patients aged 18 years or younger (1·80, 1·06-3·07). All investigated variants, except Arg160Trp, tended, to varying degrees, to have higher frequencies in young patients than in adult patients, with significantly higher frequencies found for Val60Leu (OR 1·60, 95% CI 1·05-2·44; p=0·04) and Asp294His (2·15, 1·05-4·40; p=0·04). Compared with those of healthy controls, young patients with melanoma had significantly higher frequencies of any MC1R variants.InterpretationOur pooled analysis of MC1R genetic data of young patients with melanoma showed that MC1R r variants were more prevalent in childhood and adolescent melanoma than in adult melanoma, especially in patients aged 18 years or younger. Our findings support the role of MC1R in childhood and adolescent melanoma susceptibility, with a potential clinical relevance for developing early melanoma detection and preventive strategies.FundingSPD-Pilot/Project-Award-2015; AIRC-MFAG-11831.
- Published
- 2019
22. Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes
- Author
-
Thomas, Nancy E, Edmiston, Sharon N, Orlow, Irene, Kanetsky, Peter A, Luo, Li, Gibbs, David C, Parrish, Eloise A, Hao, Honglin, Busam, Klaus J, Armstrong, Bruce K, Kricker, Anne, Cust, Anne E, Anton-Culver, Hoda, Gruber, Stephen B, Gallagher, Richard P, Zanetti, Roberto, Rosso, Stefano, Sacchetto, Lidia, Dwyer, Terence, Ollila, David W, Begg, Colin B, Berwick, Marianne, Conway, Kathleen, Begg, Colin, Roy, Pampa, Reiner, Anne, Leong, Siok, Guerrero, Sergio Corrales, Sadeghi, Keimya, Boyce, Tawny W, Venn, Alison, Tucker, Paul, Marrett, Loraine D, From, Lynn, Huang, Shu-Chen, Groben, Pamela A, Parrish, Eloise, Frank, Jill S, Rebbeck, Timothy R, Taylor, Julia Lee, and Madronich, Sasha
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Human Genome ,Cancer ,Genetic Testing ,Genetics ,Aetiology ,2.1 Biological and endogenous factors ,Adult ,Aged ,Female ,GTP Phosphohydrolases ,Genetic Association Studies ,Genotype ,Group VI Phospholipases A2 ,Humans ,Interferon Regulatory Factors ,Male ,Melanoma ,Membrane Proteins ,Middle Aged ,Mutation ,Polymorphism ,Single Nucleotide ,Proto-Oncogene Proteins B-raf ,Risk ,Skin Neoplasms ,GEM Study Group ,Clinical Sciences ,Dermatology & Venereal Diseases ,Clinical sciences - Abstract
BRAF and NRAS mutations arise early in melanoma development, but their associations with low-penetrance melanoma susceptibility loci remain unknown. In the Genes, Environment and Melanoma Study, 1,223 European-origin participants had their incident invasive primary melanomas screened for BRAF/NRAS mutations and germline DNA genotyped for 47 single-nucleotide polymorphisms identified as low-penetrant melanoma-risk variants. We used multinomial logistic regression to simultaneously examine each single-nucleotide polymorphism's relationship to BRAF V600E, BRAF V600K, BRAF other, and NRAS+ relative to BRAF-/NRAS- melanoma adjusted for study features. IRF4 rs12203592*T was associated with BRAF V600E (odds ratio [OR] = 0.59, 95% confidence interval [CI] = 0.43-0.79) and V600K (OR = 0.65, 95% CI = 0.41-1.03), but not BRAF other or NRAS+ melanoma. A global test of etiologic heterogeneity (Pglobal = 0.001) passed false discovery (Pglobal = 0.0026). PLA2G6 rs132985*T was associated with BRAF V600E (OR = 1.32, 95% CI = 1.05-1.67) and BRAF other (OR = 1.82, 95% CI = 1.11-2.98), but not BRAF V600K or NRAS+ melanoma. The test for etiologic heterogeneity (Pglobal) was 0.005. The IRF4 rs12203592 associations were slightly attenuated after adjustment for melanoma-risk phenotypes. The PLA2G6 rs132985 associations were independent of phenotypes. IRF4 and PLA2G6 inherited genotypes may influence melanoma BRAF/NRAS subtype development.
- Published
- 2018
23. Assessment of skin cancer precision prevention materials among Hispanics in Florida and Puerto Rico
- Author
-
Calderon-Casellas, Chavely, Lacson, John Charles A., Forgas, Stephanie M., Doyle, Scarlet H., Del Rio, Jocelyn, Feliciano, Adriana Ramírez, Kim, Youngchul, Roetzheim, Richard G., Sutton, Steven K., Vadaparampil, Susan T., Soto-Torres, Brenda, and Kanetsky, Peter A.
- Published
- 2022
- Full Text
- View/download PDF
24. Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial
- Author
-
Smit, Amelia K., Allen, Martin, Beswick, Brooke, Butow, Phyllis, Dawkins, Hugh, Dobbinson, Suzanne J., Dunlop, Kate L., Espinoza, David, Fenton, Georgina, Kanetsky, Peter A., Keogh, Louise, Kimlin, Michael G., Kirk, Judy, Law, Matthew H., Lo, Serigne, Low, Cynthia, Mann, Graham J., Reyes-Marcelino, Gillian, Morton, Rachael L., Newson, Ainsley J., Savard, Jacqueline, Trevena, Lyndal, Wordsworth, Sarah, and Cust, Anne E.
- Published
- 2021
- Full Text
- View/download PDF
25. The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival
- Author
-
Orlow, Irene, Shi, Yang, Kanetsky, Peter A, Thomas, Nancy E, Luo, Li, Corrales‐Guerrero, Sergio, Cust, Anne E, Sacchetto, Lidia, Zanetti, Roberto, Rosso, Stefano, Armstrong, Bruce K, Dwyer, Terence, Venn, Alison, Gallagher, Richard P, Gruber, Stephen B, Marrett, Loraine D, Anton‐Culver, Hoda, Busam, Klaus, Begg, Colin B, Berwick, Marianne, and Group, the GEM Study
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Cancer ,Climate-Related Exposures and Conditions ,Prevention ,Nutrition ,Genetics ,Female ,Genetic Predisposition to Disease ,Haplotypes ,Humans ,Male ,Melanoma ,Polymorphism ,Single Nucleotide ,Receptors ,Calcitriol ,Risk Factors ,Sunlight ,Survival Analysis ,exposure ,haplotype ,interaction ,melanoma ,polymorphism ,SNP ,survival ,UVB ,vitamin D receptor ,GEM Study Group ,Biological Sciences ,Medical and Health Sciences ,Dermatology & Venereal Diseases ,Biochemistry and cell biology ,Oncology and carcinogenesis - Abstract
Evidence on the relationship between the vitamin D pathway and outcomes in melanoma is growing, although it is not always clear. We investigated the impact of measured levels of sun exposure at diagnosis on associations of vitamin D receptor gene (VDR) polymorphisms and melanoma death in 3336 incident primary melanoma cases. Interactions between six SNPs and a common 3'-end haplotype were significant (p
- Published
- 2018
26. Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma
- Author
-
Thomas, Nancy E, Edmiston, Sharon N, Kanetsky, Peter A, Busam, Klaus J, Kricker, Anne, Armstrong, Bruce K, Cust, Anne E, Anton-Culver, Hoda, Gruber, Stephen B, Luo, Li, Orlow, Irene, Reiner, Anne S, Gallagher, Richard P, Zanetti, Roberto, Rosso, Stefano, Sacchetto, Lidia, Dwyer, Terence, Parrish, Eloise A, Hao, Honglin, Gibbs, David C, Frank, Jill S, Ollila, David W, Begg, Colin B, Berwick, Marianne, Conway, Kathleen, Roy, Pampa, Patel, Himali, Paine, Susan, Venn, Alison, Tucker, Paul, Marrett, Loraine D, From, Lynn, Huang, Shu-Chen, Groben, Pamela A, Parrish, Eloise, Bramson, Jennifer I, Rebbeck, Timothy R, Taylor, Julia Lee, and Madronich, Sasha
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Cancer ,Genetics ,Adult ,Aged ,Australia ,Female ,GTP Phosphohydrolases ,Genotype ,Humans ,Male ,Melanoma ,Membrane Proteins ,Middle Aged ,Mutation ,Phenotype ,Proto-Oncogene Proteins B-raf ,Receptor ,Melanocortin ,Type 1 ,Skin Neoplasms ,United States ,GEM Study Group ,Clinical Sciences ,Dermatology & Venereal Diseases ,Clinical sciences - Abstract
Associations of MC1R with BRAF mutations in melanoma have been inconsistent between studies. We sought to determine for 1,227 participants in the international population-based Genes, Environment, and Melanoma (GEM) study whether MC1R and phenotypes were associated with melanoma BRAF/NRAS subtypes. We used logistic regression adjusted by age, sex, and study design features and examined effect modifications. BRAF+ were associated with younger age, blond/light brown hair, increased nevi, and less freckling, and NRAS+ with older age relative to the wild type (BRAF-/NRAS-) melanomas (all P < 0.05). Comparing specific BRAF subtypes to the wild type, BRAF V600E was associated with younger age, blond/light brown hair, and increased nevi and V600K with increased nevi and less freckling (all P < 0.05). MC1R was positively associated with BRAF V600E cases but only among individuals with darker phototypes or darker hair (Pinteraction < 0.05) but inversely associated with BRAF V600K (Ptrend = 0.006) with no significant effect modification by phenotypes. These results support distinct etiologies for BRAF V600E, BRAF V600K, NRAS+, and wild-type melanomas. MC1R's associations with BRAF V600E cases limited to individuals with darker phenotypes indicate that MC1R genotypes specifically provide information about BRAF V600E melanoma risk in those not considered high risk based on phenotype. Our results also suggest that melanin pathways deserve further study in BRAF V600E melanomagenesis.
- Published
- 2017
27. Abstract A004: Patterns of lncRNA-regulated gene expression in high-grade serous ovarian carcinomas
- Author
-
Reid, Brett M., primary, Chen, Ann, additional, Chen, Zhihua, additional, Karreth, Florian A., additional, Kanetsky, Peter, additional, Permuth, Jennifer B., additional, Saglam, Ozlen, additional, Teer, Jamie K., additional, Yu, Xiaoqing, additional, Gayther, Simon, additional, Goode, Ellen, additional, Pharoah, Paul, additional, Sellers, Thomas A., additional, Lawrenson, Kate, additional, and Tyrer, Jonathan, additional
- Published
- 2024
- Full Text
- View/download PDF
28. Sun Exposure, Tanning Behaviors, and Sunburn: Examining Activities Associated With Harmful Ultraviolet Radiation Exposures in College Students
- Author
-
Bowers, Jennifer M., Hamilton, Jada G., Lobel, Marci, Kanetsky, Peter A., and Hay, Jennifer L.
- Published
- 2021
- Full Text
- View/download PDF
29. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma
- Author
-
Vernali, Steven, Waxweiler, Weston T, Dillon, Patrick M, Kanetsky, Peter A, Orlow, Irene, Luo, Li, Busam, Klaus J, Kricker, Anne, Armstrong, Bruce K, Anton-Culver, Hoda, Gruber, Stephen B, Gallagher, Richard P, Zanetti, Roberto, Rosso, Stefano, Sacchetto, Lidia, Dwyer, Terence, Cust, Anne E, Ollila, David W, Begg, Colin B, Berwick, Marianne, and Thomas, Nancy E
- Subjects
Genetics ,Clinical Research ,Climate-Related Exposures and Conditions ,Cancer ,Adult ,Aged ,Cohort Studies ,Female ,Humans ,Logistic Models ,Male ,Melanoma ,Amelanotic ,Middle Aged ,Phenotype ,Pigmentation ,Receptor ,Melanocortin ,Type 1 ,Skin Neoplasms ,GEM Study Group ,Clinical Sciences ,Oncology and Carcinogenesis - Abstract
ImportanceWe previously reported that survival is poorer from histopathologically amelanotic than pigmented melanoma because of more advanced stage at diagnosis. Identifying patients at risk of amelanotic melanoma might enable earlier diagnosis and improved survival; however, the phenotypic characteristics and underlying genetics associated with amelanotic melanoma are unknown.ObjectiveTo determine whether phenotypic characteristics, carriage of MC1R variants, and history of amelanotic melanoma are associated with histopathologically amelanotic melanoma.Design, setting, and participantsThe Genes, Environment, and Melanoma (GEM) study is an international cohort study that enrolled patients with incident primary cutaneous melanomas from population-based and hospital-based cancer registries (1998 to 2003). The GEM participants included here were 2387 patients with data for phenotypes, MC1R genotype, and primary melanomas scored for histopathologic pigmentation. Of these 2387 patients with incident melanomas scored for pigmentation, 527 had prior primary melanomas also scored for pigmentation.Main outcomes and measuresAssociations of phenotypic characteristics (freckles, nevi, phenotypic index) and MC1R status with incident amelanotic melanomas were evaluated using logistic regression models adjusted for age, sex, study center, and primary status (single or multiple primary melanoma); odds ratios (ORs) and 95% CIs are reported. Association of histopathologic pigmentation between incident and prior melanomas was analyzed using an exact logistic regression model.ResultsThis study included 2387 patients (1065 women, 1322 men; mean [SD] age at diagnosis, 58.3 [16.1] years) and 2917 primary melanomas. In a multivariable model including phenotypic characteristics, absence of back nevi, presence of many freckles, and a sun-sensitive phenotypic index were independently associated with amelanotic melanoma. Carriage of MC1R variants was associated with amelanotic melanoma but lost statistical significance in a model with phenotype. Further, patients with incident primary amelanotic melanomas were more likely to have had a prior primary amelanotic melanoma (OR, 4.62; 95% CI, 1.25-14.13) than those with incident primary pigmented melanomas.Conclusions and relevanceAbsence of back nevi, presence of many freckles, a sun-sensitive phenotypic index, and prior amelanotic melanoma increase odds for development of amelanotic melanoma. An increased index of suspicion for melanoma in presenting nonpigmented lesions and more careful examination for signs of amelanotic melanoma during periodic skin examination in patients at increased odds of amelanotic melanoma might lead to earlier diagnosis and improved survival.
- Published
- 2017
30. Variants in autophagy‐related genes and clinical characteristics in melanoma: a population‐based study
- Author
-
White, Kirsten AM, Luo, Li, Thompson, Todd A, Torres, Salina, Hu, Chien‐An Andy, Thomas, Nancy E, Lilyquist, Jenna, Anton‐Culver, Hoda, Gruber, Stephen B, From, Lynn, Busam, Klaus J, Orlow, Irene, Kanetsky, Peter A, Marrett, Loraine D, Gallagher, Richard P, Sacchetto, Lidia, Rosso, Stefano, Dwyer, Terence, Cust, Anne E, Begg, Colin B, Berwick, Marianne, Mujumdar, Urvi, Roy, Pampa, Armstrong, Bruce, Kricker, Anne, Litchfield, Melisa, Tucker, Paul, Venn, Alison, Stephens, Nicola, Switzer, Teresa, Marrett, Loraine, Theis, Elizabeth, Chowdhury, Noori, Vanasse, Louise, Zanetti, Roberto, Sacerdote, Carlotta, Leighton, Nancy, Jeter, Joanne, Klotz, Judith, Wilcox, Homer, Weiss, Helen, Mattingly, Dianne, Player, Jon, Rebbeck, Timothy, Walker, Amy, Panossian, Saarene, Taylor, Julia Lee, and Madronich, Sasha
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Cancer ,Genetics ,Clinical Research ,Aetiology ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,screening and diagnosis ,2.1 Biological and endogenous factors ,Adult ,Aged ,Alleles ,Autophagy ,Autophagy-Related Proteins ,Female ,Genetic Predisposition to Disease ,Genetic Variation ,Genotype ,Humans ,Male ,Melanoma ,Middle Aged ,Models ,Biological ,Neoplasm Staging ,Odds Ratio ,Polymorphism ,Single Nucleotide ,Population Surveillance ,ATG16L1 ,autophagy ,melanoma ,polymorphism ,SNP ,GEM Study Group ,ATG16L1 ,SNP ,Biochemistry and Cell Biology ,Oncology and carcinogenesis - Abstract
Autophagy has been linked with melanoma risk and survival, but no polymorphisms in autophagy-related (ATG) genes have been investigated in relation to melanoma progression. We examined five single-nucleotide polymorphisms (SNPs) in three ATG genes (ATG5; ATG10; and ATG16L) with known or suspected impact on autophagic flux in an international population-based case-control study of melanoma. DNA from 911 melanoma patients was genotyped. An association was identified between (GG) (rs2241880) and earlier stage at diagnosis (OR 0.47; 95% Confidence Intervals (CI) = 0.27-0.81, P = 0.02) and a decrease in Breslow thickness (P = 0.03). The ATG16L heterozygous genotype (AG) (rs2241880) was associated with younger age at diagnosis (P = 0.02). Two SNPs in ATG5 were found to be associated with increased stage (rs2245214 CG, OR 1.47; 95% CI = 1.11-1.94, P = 0.03; rs510432 CC, OR 1.84; 95% CI = 1.12-3.02, P = 0.05). Finally, we identified inverse associations between ATG5 (GG rs2245214) and melanomas on the scalp or neck (OR 0.20, 95% CI = 0.05-0.86, P = 0.03); ATG10 (CC) (rs1864182) and brisk tumor infiltrating lymphocytes (TILs) (OR 0.42; 95% CI = 0.21-0.88, P = 0.02), and ATG5 (CC) (rs510432) with nonbrisk TILs (OR 0.55; 95% CI = 0.34-0.87, P = 0.01). Our data suggest that ATG SNPs might be differentially associated with specific host and tumor characteristics including age at diagnosis, TILs, and stage. These associations may be critical to understanding the role of autophagy in cancer, and further investigation will help characterize the contribution of these variants to melanoma progression.
- Published
- 2016
31. Lack of pathogenic germline DICER1 variants in males with testicular germ-cell tumors
- Author
-
Vasta, Lauren M., McMaster, Mary L., Harney, Laura A., Ling, Alexander, Kim, Jung, Harris, Anne K., Carr, Ann G., Damrauer, Scott M., Rader, Daniel J., Kember, Rachel L., Kanetsky, Peter A., Nathanson, Katherine L., Pyle, Louise C., Greene, Mark H., Schultz, Kris Ann, and Stewart, Douglas R.
- Published
- 2020
- Full Text
- View/download PDF
32. Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma
- Author
-
Taylor, Nicholas J, Thomas, Nancy E, Anton‐Culver, Hoda, Armstrong, Bruce K, Begg, Colin B, Busam, Klaus J, Cust, Anne E, Dwyer, Terence, From, Lynn, Gallagher, Richard P, Gruber, Stephen B, Nishri, Diane E, Orlow, Irene, Rosso, Stefano, Venn, Alison J, Zanetti, Roberto, Berwick, Marianne, Kanetsky, Peter A, and Group, on behalf of the GEM Study
- Subjects
Cancer ,Clinical Research ,Climate-Related Exposures and Conditions ,Adult ,Aged ,Case-Control Studies ,Female ,Humans ,Kaplan-Meier Estimate ,Male ,Melanoma ,Middle Aged ,Nevus ,Pigmented ,Odds Ratio ,Phenotype ,Population Surveillance ,Prognosis ,Proportional Hazards Models ,Risk Factors ,Skin Neoplasms ,melanoma ,disease-specific survival ,nevi ,phenotypic characteristics ,GEM Study Group ,Oncology and Carcinogenesis ,Oncology & Carcinogenesis - Abstract
Although nevus count is an established risk factor for melanoma, relationships between nevus number and patient and tumor characteristics have not been well studied and the influence of nevus count on melanoma-specific survival is equivocal. Using data from the Genes, Environment and Melanoma (GEM) study, a large population-based study of primary cutaneous melanoma, we evaluated associations between number of nevi and patient features, including sun-sensitivity summarized in a phenotypic index, and tumor characteristics. We also assessed the association of nevus count with melanoma-specific survival. Higher nevus counts were independently and positively associated with male gender and younger age at diagnosis, and they were inversely associated with lentigo maligna histology. We observed a borderline significant trend of poorer melanoma-specific survival with increasing quartile of nevus count, but little or no association between number of nevi and pigmentary phenotypic characteristics or prognostic tumor features.
- Published
- 2016
33. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways
- Author
-
Gibbs, David C, Orlow, Irene, Bramson, Jennifer I, Kanetsky, Peter A, Luo, Li, Kricker, Anne, Armstrong, Bruce K, Anton-Culver, Hoda, Gruber, Stephen B, Marrett, Loraine D, Gallagher, Richard P, Zanetti, Roberto, Rosso, Stefano, Dwyer, Terence, Sharma, Ajay, La Pilla, Emily, From, Lynn, Busam, Klaus J, Cust, Anne E, Ollila, David W, Begg, Colin B, Berwick, Marianne, and Thomas, Nancy E
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Climate-Related Exposures and Conditions ,Cancer ,Genetics ,2.1 Biological and endogenous factors ,Aetiology ,Adult ,Age of Onset ,Aged ,Female ,Genetic Predisposition to Disease ,Genotype ,Humans ,Interferon Regulatory Factors ,Logistic Models ,Male ,Melanoma ,Middle Aged ,Odds Ratio ,Phenotype ,Polymorphism ,Single Nucleotide ,Principal Component Analysis ,Skin Neoplasms ,Sunlight ,Whites ,GEM Study Group ,White People ,Oncology & Carcinogenesis ,Oncology and carcinogenesis - Abstract
BackgroundSolar elastosis and neval remnants are histologic markers characteristic of divergent melanoma pathways linked to differences in age at onset, host phenotype, and sun exposure. However, the association between these pathway markers and newly identified low-penetrance melanoma susceptibility loci remains unknown.MethodsIn the Genes, Environment and Melanoma (GEM) Study, 2103 Caucasian participants had first primary melanomas that underwent centralized pathology review. For 47 single-nucleotide polymorphisms (SNPs) previously identified as low-penetrant melanoma risk variants, we used multinomial logistic regression to compare melanoma with solar elastosis and melanoma with neval remnants simultaneously to melanoma with neither of these markers, excluding melanomas with both markers. All statistical tests were two-sided.ResultsIRF4 rs12203592 was the only SNP to pass the false discovery threshold in baseline models adjusted for age, sex, and study center. rs12203592*T was associated positively with melanoma with solar elastosis (odds ratio [OR] = 1.47, 95% confidence interval [CI] = 1.18 to 1.82) and inversely with melanoma with neval remnants (OR = 0.65, 95% CI = 0.48 to 0.87) compared with melanoma with neither marker (P global = 3.78 x 10(-08)). Adjusting for phenotypic characteristics and total sun exposure hours did not materially affect rs12203592's associations. Distinct early- and late-onset age distributions were observed in patients with IRF4 rs12203592 [CC] and [TT] genotypes, respectively.ConclusionsOur findings suggest a role of IRF4 rs12203592 in pathway-specific risk for melanoma development. We hypothesize that IRF4 rs12203592 could underlie in part the bimodal age distribution reported for melanoma and linked to the divergent pathways.
- Published
- 2016
34. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study
- Author
-
Orlow, Irene, Reiner, Anne S, Thomas, Nancy E, Roy, Pampa, Kanetsky, Peter A, Luo, Li, Paine, Susan, Armstrong, Bruce K, Kricker, Anne, Marrett, Loraine D, Rosso, Stefano, Zanetti, Roberto, Gruber, Stephen B, Anton-Culver, Hoda, Gallagher, Richard P, Dwyer, Terence, Busam, Klaus, Begg, Colin B, and Berwick, Marianne
- Subjects
Genetics ,Nutrition ,Cancer ,Genetic Testing ,Australia ,Canada ,Female ,Genotype ,Haplotypes ,Humans ,Italy ,Male ,Melanoma ,Polymorphism ,Single Nucleotide ,Proportional Hazards Models ,Receptors ,Calcitriol ,Skin Neoplasms ,United States ,GEM Study Group ,Oncology and Carcinogenesis ,Oncology & Carcinogenesis - Abstract
Factors known to affect melanoma survival include age at presentation, sex and tumor characteristics. Polymorphisms also appear to modulate survival following diagnosis. Result from other studies suggest that vitamin D receptor (VDR) polymorphisms (SNPs) impact survival in patients with glioma, renal cell carcinoma, lung, breast, prostate and other cancers; however, a comprehensive study of VDR polymorphisms and melanoma-specific survival is lacking. We aimed to investigate whether VDR genetic variation influences survival in patients with cutaneous melanoma. The analysis involved 3566 incident single and multiple primary melanoma cases enrolled in the international population-based Genes, Environment, and Melanoma Study. Melanoma-specific survival outcomes were calculated for each of 38 VDR SNPs using a competing risk analysis after adjustment for covariates. There were 254 (7.1%) deaths due to melanoma during the median 7.6 years follow-up period. VDR SNPs rs7299460, rs3782905, rs2239182, rs12370156, rs2238140, rs7305032, rs1544410 (BsmI) and rs731236 (TaqI) each had a statistically significant (trend P values < 0.05) association with melanoma-specific survival in multivariate analysis. One functional SNP (rs2239182) remained significant after adjustment for multiple testing using the Monte Carlo method. None of the SNPs associated with survival were significantly associated with Breslow thickness, ulceration or mitosis. These results suggest that the VDR gene may influence survival from melanoma, although the mechanism by which VDR exerts its effect does not seem driven by tumor aggressiveness. Further investigations are needed to confirm our results and to understand the relationship between VDR and survival in the combined context of tumor and host characteristics.
- Published
- 2016
35. Identification of 22 susceptibility loci associated with testicular germ cell tumors
- Author
-
Pluta, John, Pyle, Louise C., Nead, Kevin T., Wilf, Rona, Li, Mingyao, Mitra, Nandita, Weathers, Benita, D’Andrea, Kurt, Almstrup, Kristian, Anson-Cartwright, Lynn, Benitez, Javier, Brown, Christopher D., Chanock, Stephen, Chen, Chu, Cortessis, Victoria K., Ferlin, Alberto, Foresta, Carlo, Gamulin, Marija, Gietema, Jourik A., Grasso, Chiara, Greene, Mark H., Grotmol, Tom, Hamilton, Robert J., Haugen, Trine B., Hauser, Russ, Hildebrandt, Michelle A. T., Johnson, Matthew E., Karlsson, Robert, Kiemeney, Lambertus A., Lessel, Davor, Lothe, Ragnhild A., Loud, Jennifer T., Loveday, Chey, Martin-Gimeno, Paloma, Meijer, Coby, Nsengimana, Jérémie, Quinn, David I., Rafnar, Thorunn, Ramdas, Shweta, Richiardi, Lorenzo, Skotheim, Rolf I., Stefansson, Kari, Turnbull, Clare, Vaughn, David J., Wiklund, Fredrik, Wu, Xifeng, Yang, Daphne, Zheng, Tongzhang, Wells, Andrew D., Grant, Struan F. A., Rajpert-De Meyts, Ewa, Schwartz, Stephen M., Bishop, D. Timothy, McGlynn, Katherine A., Kanetsky, Peter A., and Nathanson, Katherine L.
- Published
- 2021
- Full Text
- View/download PDF
36. Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma
- Author
-
Reid, Brett M., Vyas, Shraddha, Chen, Zhihua, Chen, Ann, Kanetsky, Peter A., Permuth, Jennifer B., Sellers, Thomas A., and Saglam, Ozlen
- Published
- 2021
- Full Text
- View/download PDF
37. Non-del(5q) myelodysplastic syndromes–associated loci detected by SNP-array genome-wide association meta-analysis
- Author
-
McGraw, Kathy L., Cheng, Chia-Ho, Chen, Y. Ann, Hou, Hsin-An, Nilsson, Björn, Genovese, Giulio, Cluzeau, Thomas, Pellagatti, Andrea, Przychodzen, Bartlomiej P., Mallo, Mar, Arenillas, Leonor, Mohamedali, Azim, Adès, Lionel, Sallman, David A., Padron, Eric, Sokol, Lubomir, Moreilhon, Chimene, Raynaud, Sophie, Tien, Hwei-Fang, Boultwood, Jacqueline, Ebert, Benjamin L., Sole, Francesc, Fenaux, Pierre, Mufti, Ghulam J., Maciejewski, Jaroslaw P., Kanetsky, Peter A., and List, Alan F.
- Published
- 2019
- Full Text
- View/download PDF
38. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
- Author
-
Landi, Maria Teresa, Bishop, D. Timothy, MacGregor, Stuart, Machiela, Mitchell J., Stratigos, Alexander J., Ghiorzo, Paola, Brossard, Myriam, Calista, Donato, Choi, Jiyeon, Fargnoli, Maria Concetta, Zhang, Tongwu, Rodolfo, Monica, Trower, Adam J., Menin, Chiara, Martinez, Jacobo, Hadjisavvas, Andreas, Song, Lei, Stefanaki, Irene, Scolyer, Richard, Yang, Rose, Goldstein, Alisa M., Potrony, Miriam, Kypreou, Katerina P., Pastorino, Lorenza, Queirolo, Paola, Pellegrini, Cristina, Cattaneo, Laura, Zawistowski, Matthew, Gimenez-Xavier, Pol, Rodriguez, Arantxa, Elefanti, Lisa, Manoukian, Siranoush, Rivoltini, Licia, Smith, Blair H., Loizidou, Maria A., Del Regno, Laura, Massi, Daniela, Mandala, Mario, Khosrotehrani, Kiarash, Akslen, Lars A., Amos, Christopher I., Andresen, Per A., Avril, Marie-Françoise, Azizi, Esther, Soyer, H. Peter, Bataille, Veronique, Dalmasso, Bruna, Bowdler, Lisa M., Burdon, Kathryn P., Chen, Wei V., Codd, Veryan, Craig, Jamie E., Dębniak, Tadeusz, Falchi, Mario, Fang, Shenying, Friedman, Eitan, Simi, Sarah, Galan, Pilar, Garcia-Casado, Zaida, Gillanders, Elizabeth M., Gordon, Scott, Green, Adele, Gruis, Nelleke A., Hansson, Johan, Harland, Mark, Harris, Jessica, Helsing, Per, Henders, Anjali, Hočevar, Marko, Höiom, Veronica, Hunter, David, Ingvar, Christian, Kumar, Rajiv, Lang, Julie, Lathrop, G. Mark, Lee, Jeffrey E., Li, Xin, Lubiński, Jan, Mackie, Rona M., Malt, Maryrose, Malvehy, Josep, McAloney, Kerrie, Mohamdi, Hamida, Molven, Anders, Moses, Eric K., Neale, Rachel E., Novaković, Srdjan, Nyholt, Dale R., Olsson, Håkan, Orr, Nicholas, Fritsche, Lars G., Puig-Butille, Joan Anton, Qureshi, Abrar A., Radford-Smith, Graham L., Randerson-Moor, Juliette, Requena, Celia, Rowe, Casey, Samani, Nilesh J., Sanna, Marianna, Schadendorf, Dirk, Schulze, Hans-Joachim, Simms, Lisa A., Smithers, Mark, Song, Fengju, Swerdlow, Anthony J., van der Stoep, Nienke, Kukutsch, Nicole A., Visconti, Alessia, Wallace, Leanne, Ward, Sarah V., Wheeler, Lawrie, Sturm, Richard A., Hutchinson, Amy, Jones, Kristine, Malasky, Michael, Vogt, Aurelie, Zhou, Weiyin, Pooley, Karen A., Elder, David E., Han, Jiali, Hicks, Belynda, Hayward, Nicholas K., Kanetsky, Peter A., Brummett, Chad, Montgomery, Grant W., Olsen, Catherine M., Hayward, Caroline, Dunning, Alison M., Martin, Nicholas G., Evangelou, Evangelos, Mann, Graham J., Long, Georgina, Pharoah, Paul D. P., Easton, Douglas F., Barrett, Jennifer H., Cust, Anne E., Abecasis, Goncalo, Duffy, David L., Whiteman, David C., Gogas, Helen, De Nicolo, Arcangela, Tucker, Margaret A., Newton-Bishop, Julia A., Peris, Ketty, Chanock, Stephen J., Demenais, Florence, Brown, Kevin M., Puig, Susana, Nagore, Eduardo, Shi, Jianxin, Iles, Mark M., and Law, Matthew H.
- Published
- 2020
- Full Text
- View/download PDF
39. Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma
- Author
-
Gibbs, David C, Orlow, Irene, Kanetsky, Peter A, Luo, Li, Kricker, Anne, Armstrong, Bruce K, Anton-Culver, Hoda, Gruber, Stephen B, Marrett, Loraine D, Gallagher, Richard P, Zanetti, Roberto, Rosso, Stefano, Dwyer, Terence, Sharma, Ajay, La Pilla, Emily, From, Lynn, Busam, Klaus J, Cust, Anne E, Ollila, David W, Begg, Colin B, Berwick, Marianne, and Thomas, Nancy E
- Subjects
Genetics ,Clinical Research ,Cancer ,Australia ,Biomarkers ,Tumor ,Canada ,Case-Control Studies ,Europe ,Follow-Up Studies ,Genetic Predisposition to Disease ,Genome-Wide Association Study ,Haplotypes ,Humans ,International Agencies ,Melanoma ,Neoplasm Invasiveness ,Neoplasm Staging ,Phenotype ,Polymorphism ,Single Nucleotide ,Prognosis ,Skin Neoplasms ,United States ,GEM Study Group ,Medical and Health Sciences ,Epidemiology - Abstract
Recent studies, including genome-wide association studies, have identified several putative low-penetrance susceptibility loci for melanoma. We sought to determine their generalizability to genetic predisposition for multiple primary melanoma in the international population-based Genes, Environment, and Melanoma (GEM) Study. GEM is a case-control study of 1,206 incident cases of multiple primary melanoma and 2,469 incident first primary melanoma participants as the control group. We investigated the odds of developing multiple primary melanoma for 47 SNPs from 21 distinct genetic regions previously reported to be associated with melanoma. ORs and 95% confidence intervals were determined using logistic regression models adjusted for baseline features (age, sex, age by sex interaction, and study center). We investigated univariable models and built multivariable models to assess independent effects of SNPs. Eleven SNPs in 6 gene neighborhoods (TERT/CLPTM1L, TYRP1, MTAP, TYR, NCOA6, and MX2) and a PARP1 haplotype were associated with multiple primary melanoma. In a multivariable model that included only the most statistically significant findings from univariable modeling and adjusted for pigmentary phenotype, back nevi, and baseline features, we found TERT/CLPTM1L rs401681 (P = 0.004), TYRP1 rs2733832 (P = 0.006), MTAP rs1335510 (P = 0.0005), TYR rs10830253 (P = 0.003), and MX2 rs45430 (P = 0.008) to be significantly associated with multiple primary melanoma, while NCOA6 rs4911442 approached significance (P = 0.06). The GEM Study provides additional evidence for the relevance of these genetic regions to melanoma risk and estimates the magnitude of the observed genetic effect on development of subsequent primary melanoma.
- Published
- 2015
40. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
- Author
-
Thomas, Nancy E, Edmiston, Sharon N, Alexander, Audrey, Groben, Pamela A, Parrish, Eloise, Kricker, Anne, Armstrong, Bruce K, Anton-Culver, Hoda, Gruber, Stephen B, From, Lynn, Busam, Klaus J, Hao, Honglin, Orlow, Irene, Kanetsky, Peter A, Luo, Li, Reiner, Anne S, Paine, Susan, Frank, Jill S, Bramson, Jennifer I, Marrett, Lorraine D, Gallagher, Richard P, Zanetti, Roberto, Rosso, Stefano, Dwyer, Terence, Cust, Anne E, Ollila, David W, Begg, Colin B, Berwick, Marianne, and Conway, Kathleen
- Subjects
Clinical Research ,Cancer ,Adult ,Aged ,Aged ,80 and over ,Biomarkers ,Tumor ,DNA Mutational Analysis ,Female ,GTP Phosphohydrolases ,Gene Frequency ,Genetic Predisposition to Disease ,Humans ,Kaplan-Meier Estimate ,Lymphocytes ,Tumor-Infiltrating ,Male ,Melanoma ,Membrane Proteins ,Middle Aged ,Multivariate Analysis ,Mutation ,Neoplasm Grading ,Neoplasm Staging ,New South Wales ,Odds Ratio ,Phenotype ,Proportional Hazards Models ,Proto-Oncogene Proteins B-raf ,Risk Assessment ,Risk Factors ,Skin Neoplasms ,Time Factors ,Tumor Microenvironment ,United States ,GEM Study Group ,Oncology and Carcinogenesis ,Public Health and Health Services - Abstract
ImportanceNRAS and BRAF mutations in melanoma inform current treatment paradigms, but their role in survival from primary melanoma has not been established. Identification of patients at high risk of melanoma-related death based on their primary melanoma characteristics before evidence of recurrence could inform recommendations for patient follow-up and eligibility for adjuvant trials.ObjectiveTo determine tumor characteristics and survival from primary melanoma by somatic NRAS and BRAF status.Design, setting, and participantsA population-based study with a median follow-up of 7.6 years (through 2007), including 912 patients from the United States and Australia in the Genes, Environment, and Melanoma (GEM) Study, with first primary cutaneous melanoma diagnosed in the year 2000 and analyzed for NRAS and BRAF mutations.Main outcomes and measuresTumor characteristics and melanoma-specific survival of primary melanoma by NRAS and BRAF mutational status.ResultsThe melanomas were 13% NRAS+, 30% BRAF+, and 57% with neither NRAS nor BRAF mutation (wildtype [WT]). In a multivariable model including clinicopathologic characteristics, relative to WT melanoma (with results reported as odds ratios [95% CIs]), NRAS+ melanoma was associated with presence of mitoses (1.8 [1.0-3.3]), lower tumor-infiltrating lymphocyte (TIL) grade (nonbrisk, 0.5 [0.3-0.8]; and brisk, 0.3 [0.5-0.7] [vs absent TILs]), and anatomic site other than scalp/neck (0.1 [0.01-0.6] for scalp/neck vs trunk/pelvis), and BRAF+ melanoma was associated with younger age (ages 50-69 years, 0.7 [0.5-1.0]; and ages >70 years, 0.5 [0.3-0.8] [vs
- Published
- 2015
41. Inherited variation at MC1R and ASIP and association with melanoma‐specific survival
- Author
-
Taylor, Nicholas J, Reiner, Anne S, Begg, Colin B, Cust, Anne E, Busam, Klaus J, Anton‐Culver, Hoda, Dwyer, Terence, From, Lynn, Gallagher, Richard P, Gruber, Stephen B, Rosso, Stefano, White, Kirsten A, Zanetti, Roberto, Orlow, Irene, Thomas, Nancy E, Rebbeck, Timothy R, Berwick, Marianne, Kanetsky, Peter A, and Group, on behalf of the GEM Study
- Subjects
Human Genome ,Cancer ,Genetics ,Adult ,Aged ,Aged ,80 and over ,Agouti Signaling Protein ,Female ,Genetic Association Studies ,Genetic Variation ,Genotype ,Heredity ,Humans ,Male ,Melanoma ,Middle Aged ,Polymorphism ,Single Nucleotide ,Proportional Hazards Models ,Receptor ,Melanocortin ,Type 1 ,Young Adult ,MC1R ,melanoma ,survival ,ASIP ,GEM study ,GEM Study Group ,Oncology and Carcinogenesis ,Oncology & Carcinogenesis - Abstract
Melanocortin-1 receptor (MC1R) is a marker of melanoma risk in populations of European ancestry. However, MC1R effects on survival are much less studied. We investigated associations between variation at MC1R and survival in an international, population-based series of single primary melanoma patients enrolled into the Genes, Environment, and Melanoma study. MC1R genotype data was available for 2,200 participants with a first incident primary melanoma diagnosis. We estimated the association of MC1R genotypes with melanoma-specific survival (i.e., death caused by melanoma) and overall survival using COX proportional hazards modeling, adjusting for established prognostic factors for melanoma. We also conducted stratified analyses by Breslow thickness, tumor site, phenotypic index, and age. In addition, we evaluated haplotypes involving polymorphisms near the Agouti signaling protein gene (ASIP) locus for their impacts on survival. Melanoma-specific survival was inversely associated with carriage of MC1R variants in the absence of consensus alleles compared to carriage of at least one consensus allele (hazard ratio (HR) = 0.60; 95% confidence interval (CI): 0.40, 0.90). MC1R results for overall survival were consistent with no association. We did not observe any statistical evidence of heterogeneity of effect estimates in stratified analyses. We observed increased hazard of melanoma-specific death among carriers of the risk haplotype TG near the ASIP locus (HR = 1.37; 95% CI: 0.91, 2.04) when compared to carriers of the most common GG haplotype. Similar results were noted for overall survival. Upon examining the ASIP TG/TG diplotype, we observed considerably increased hazard of melanoma-specific death (HR = 5.11; 95% CI: 1.88, 13.88) compared to carriers of the most common GG/GG diplotype. Our data suggest improved melanoma-specific survival among carriers of two inherited MC1R variants.
- Published
- 2015
42. Inherited variation at MC1R and histological characteristics of primary melanoma.
- Author
-
Taylor, Nicholas J, Busam, Klaus J, From, Lynn, Groben, Pamela A, Anton-Culver, Hoda, Cust, Anne E, Begg, Colin B, Dwyer, Terence, Gallagher, Richard P, Gruber, Stephen B, Orlow, Irene, Rosso, Stefano, Thomas, Nancy E, Zanetti, Roberto, Rebbeck, Timothy R, Berwick, Marianne, and Kanetsky, Peter A
- Subjects
Humans ,Melanoma ,Skin Neoplasms ,Receptor ,Melanocortin ,Type 1 ,Skin Pigmentation ,Risk Factors ,Genotype ,Polymorphism ,Single Nucleotide ,Genetic Association Studies ,General Science & Technology - Abstract
Variation in the melanocortin-1receptor (MC1R) gene is associated with pigmentary phenotypes and risk of malignant melanoma. Few studies have reported on MC1R variation with respect to tumor characteristics, especially clinically important prognostic features. We examined associations between MC1R variants and histopathological melanoma characteristics. Study participants were enrolled from nine geographic regions in Australia, Canada, Italy and the United States and were genotyped for MC1R variants classified as high-risk [R] (D84E, R142H, R151C, R160W, and D294H, all nonsense and insertion/deletion) or low-risk [r] (all other nonsynonymous) variants. Tissue was available for 2,160 white participants of the Genes, Environment and Melanoma (GEM) Study with a first incident primary melanoma diagnosis, and underwent centralized pathologic review. No statistically significant associations were observed between MC1R variants and AJCC established prognostic tumor characteristics: Breslow thickness, presence of mitoses or presence of ulceration. However, MC1R was significantly associated with anatomic site of melanoma (p = 0.002) and a positive association was observed between carriage of more than one [R] variant and melanomas arising on the arms (OR = 2.39; 95% CI: 1.40, 4.09). We also observed statistically significant differences between sun-sensitive and sun-resistant individuals with respect to associations between MC1R genotype and AJCC prognostic tumor characteristics. Our results suggest inherited variation in MC1R may play an influential role in anatomic site presentation of melanomas and may differ with respect to skin pigmentation phenotype.
- Published
- 2015
43. Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study
- Author
-
Thomas, Nancy E, Kricker, Anne, Waxweiler, Weston T, Dillon, Patrick M, Busam, Klaus J, From, Lynn, Groben, Pamela A, Armstrong, Bruce K, Anton-Culver, Hoda, Gruber, Stephen B, Marrett, Loraine D, Gallagher, Richard P, Zanetti, Roberto, Rosso, Stefano, Dwyer, Terence, Venn, Alison, Kanetsky, Peter A, Orlow, Irene, Paine, Susan, Ollila, David W, Reiner, Anne S, Luo, Li, Hao, Honglin, Frank, Jill S, Begg, Colin B, and Berwick, Marianne
- Subjects
Cancer ,Clinical Research ,Adult ,Aged ,Australia ,Canada ,Female ,Follow-Up Studies ,Humans ,Italy ,Male ,Melanoma ,Melanoma ,Amelanotic ,Middle Aged ,Mitotic Index ,Neoplasm Staging ,Registries ,Skin Neoplasms ,Survival Rate ,United States ,Genes ,Environment ,and Melanoma (GEM) Study Group ,Clinical Sciences ,Oncology and Carcinogenesis - Abstract
IMPORTANCE Previous studies have reported that histopathologically amelanotic melanoma is associated with poorer survival than pigmented melanoma; however, small numbers of amelanotic melanomas, selected populations, lack of centralized pathologic review, or no adjustment for stage limit the interpretation or generalization of results from prior studies.OBJECTIVE To compare melanoma-specific survival between patients with histopathologically amelanotic and those with pigmented melanoma in a large international population-based study.DESIGN, SETTING, AND PARTICIPANTS Survival analysis with a median follow-up of 7.6 years.The study population comprised 2995 patients with 3486 invasive primary melanomas centrally scored for histologic pigmentation from the Genes, Environment, and Melanoma(GEM) Study, which enrolled incident cases of melanoma diagnosed in 1998 through 2003 from international population-based cancer registries.MAIN OUTCOMES AND MEASURES Clinicopathologic predictors and melanoma-specific survival of histologically amelanotic and pigmented melanoma were compared using generalized estimating equations and Cox regression models, respectively.RESULTS Of 3467 melanomas, 275 (8%) were histopathologically amelanotic. Female sex,nodular and unclassified or other histologic subtypes, increased Breslow thickness, presence of mitoses, severe solar elastosis, and lack of a coexisting nevus were independently associated with amelanotic melanoma (each P < .05). Amelanotic melanoma was generally ofa higher American Joint Committee on Cancer (AJCC) tumor stage at diagnosis (odds ratios[ORs] [95%CIs] between 2.9 [1.8-4.6] and 11.1 [5.8-21.2] for tumor stages between T1b and T3b and ORs [95%CIs] of 24.6 [13.6-44.4] for T4a and 29.1 [15.5-54.9] for T4b relative to T1a;P value for trend,
- Published
- 2014
44. Sociodemographic and lifestyle factors associated with the neutrophil-to-lymphocyte ratio
- Author
-
Howard, Rachel, Scheiner, Aaron, Kanetsky, Peter A., and Egan, Kathleen M.
- Published
- 2019
- Full Text
- View/download PDF
45. Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies
- Author
-
Mann, Graham J., Cust, Anne E., Schmid, Helen, Hopper, John L., Aitken, Joanne F., Armstrong, Bruce K., Giles, Graham G., Holland, Elizabeth, Kefford, Richard F., Jenkins, Mark A., Newton Bishop, Julia A., Affleck, Paul, Barrett, Jennifer H., Bishop, D. Timothy, Harrison, Jane, Iles, Mark M., Randerson-Moor, Juliette, Harland, Mark, Taylor, John C., Whittaker, Linda, Kukalizch, Kairen, Leake, Susan, Karpavicius, Birute, Haynes, Sue, Mack, Tricia, Chan, May, Taylor, Yvonne, Davies, John, King, Paul, Drummond, Martin, Kanetsky, Peter A., Goldstein, Alisa M., MacGregor, Stuart, Law, Matthew H., Bui, Minh, Brossard, Myriam, Demenais, Florence, Hoggart, Clive, Brown, Kevin M., Landi, Maria Teresa, and Newton-Bishop, Julia A.
- Published
- 2018
- Full Text
- View/download PDF
46. Sun Exposure and Melanoma Survival: A GEM Study
- Author
-
Berwick, Marianne, Reiner, Anne S, Paine, Susan, Armstrong, Bruce K, Kricker, Anne, Goumas, Chris, Cust, Anne E, Thomas, Nancy E, Groben, Pamela A, From, Lynn, Busam, Klaus, Orlow, Irene, Marrett, Loraine D, Gallagher, Richard P, Gruber, Stephen B, Anton-Culver, Hoda, Rosso, Stefano, Zanetti, Roberto, Kanetsky, Peter A, Dwyer, Terry, Venn, Alison, Lee-Taylor, Julia, Begg, Colin B, and Group, for the GEM Study
- Subjects
Biomedical and Clinical Sciences ,Climate-Related Exposures and Conditions ,Clinical Research ,Cancer ,Female ,Humans ,Male ,Melanoma ,Proportional Hazards Models ,Skin Neoplasms ,Sunburn ,Sunlight ,GEM Study Group ,Medical and Health Sciences ,Epidemiology ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundWe previously reported a significant association between higher UV radiation exposure before diagnosis and greater survival with melanoma in a population-based study in Connecticut. We sought to evaluate the hypothesis that sun exposure before diagnosis was associated with greater survival in a larger, international population-based study with more detailed exposure information.MethodsWe conducted a multicenter, international population-based study in four countries-Australia, Italy, Canada, and the United States-with 3,578 cases of melanoma with an average of 7.4 years of follow-up. Measures of sun exposure included sunburn, intermittent exposure, hours of holiday sun exposure, hours of water-related outdoor activities, ambient ultraviolet B (280-320 nm) dose, histologic solar elastosis, and season of diagnosis.ResultsResults were not strongly supportive of the earlier hypothesis. Having had any sunburn in 1 year within 10 years of diagnosis was inversely associated with survival; solar elastosis-a measure of lifetime cumulative exposure-was not. In addition, none of the intermittent exposure measures-water-related activities and sunny holidays-were associated with melanoma-specific survival. Estimated ambient UVB dose was not associated with survival.ConclusionAlthough there was an apparent protective effect of sunburns within 10 years of diagnosis, there was only weak evidence in this large, international, population-based study of melanoma that sun exposure before diagnosis is associated with greater melanoma-specific survival.ImpactThis study adds to the evidence that sun exposure before melanoma diagnosis has little effect on survival with melanoma.
- Published
- 2014
47. Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes
- Author
-
Berwick, Marianne, Begg, Colin, Orlow, Irene, Busam, Klaus J., Roy, Pampa, Reiner, Anne, Leong, Siok, Guerrero, Sergio Corrales, Sadeghi, Keimya, Luo, Li, Boyce, Tawny W., Cust, Anne E., Armstrong, Bruce K., Kricker, Anne, Venn, Alison, Dwyer, Terence, Tucker, Paul, Gallagher, Richard P., Marrett, Loraine D., From, Lynn, Zanetti, Roberto, Rosso, Stefano, Anton-Culver, Hoda, Gruber, Stephen B., Huang, Shu-Chen, Thomas, Nancy E., Conway, Kathleen, Ollila, David W., Groben, Pamela A., Edmiston, Sharon N., Hao, Honglin, Parrish, Eloise, Frank, Jill S., Gibbs, David C., Rebbeck, Timothy R., Kanetsky, Peter A., Lee Taylor, Julia, Madronich, Sasha, Parrish, Eloise A., Sacchetto, Lidia, and Begg, Colin B.
- Published
- 2018
- Full Text
- View/download PDF
48. MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors
- Author
-
Berwick, Marianne, MacArthur, Jamie, Orlow, Irene, Kanetsky, Peter, Begg, Colin B, Luo, Li, Reiner, Anne, Sharma, Ajay, Armstrong, Bruce K, Kricker, Anne, Cust, Anne E, Marrett, Loraine D, Gruber, Stephen B, Anton‐Culver, Hoda, Zanetti, Roberto, Rosso, Stefano, Gallagher, Richard P, Dwyer, Terence, Venn, Alison, Busam, Klaus, From, Lynn, White, Kirsten, Thomas, Nancy E, and Group, the GEM Study
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Genetics ,Cancer ,Clinical Research ,Human Genome ,Aetiology ,2.1 Biological and endogenous factors ,Alleles ,Amino Acid Substitution ,Consensus Sequence ,Gene Frequency ,Hair Color ,Humans ,Melanoma ,Microphthalmia-Associated Transcription Factor ,Mutation ,Missense ,Neoplasm Proteins ,Neoplasms ,Multiple Primary ,Nevus ,Pigmented ,Odds Ratio ,Phenotype ,Point Mutation ,Protein Processing ,Post-Translational ,Risk ,Risk Factors ,Skin Neoplasms ,Sumoylation ,Case-controlstudy ,melanoma ,MITF ,risk factors ,single nucleotide polymorphism ,GEM Study Group ,Biological Sciences ,Medical and Health Sciences ,Dermatology & Venereal Diseases ,Biochemistry and cell biology ,Oncology and carcinogenesis - Abstract
A rare germline variant in the microphthalmia-associated transcription factor (MITF) gene, E318K, has been reported as associated with melanoma. We confirmed its independent association with melanoma [odds ratio (OR) 1.7, 95% confidence interval (CI) = 1.1, 2.7, P = 0.03]; adjusted for age, sex, center, age × sex interaction, pigmentation characteristics, family history of melanoma, and nevus density). In stratified analyses, carriage of MITF E318K was associated with melanoma more strongly in people with dark hair than fair hair (P for interaction, 0.03) and in those with no moles than some or many moles (P for interaction,
- Published
- 2014
49. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.
- Author
-
Thomas, Nancy, Busam, Klaus, From, Lynn, Kricker, Anne, Armstrong, Bruce, Gruber, Stephen, Gallagher, Richard, Zanetti, Roberto, Rosso, Stefano, Dwyer, Terence, Venn, Alison, Kanetsky, Peter, Groben, Pamela, Hao, Honglin, Orlow, Irene, Reiner, Anne, Luo, Li, Paine, Susan, Ollila, David, Wilcox, Homer, Begg, Colin, Berwick, Marianne, and Anton-Culver, Hoda
- Subjects
Adult ,Aged ,Female ,Follow-Up Studies ,Gene-Environment Interaction ,Humans ,Kaplan-Meier Estimate ,Lymphocytes ,Tumor-Infiltrating ,Male ,Melanoma ,Middle Aged ,Neoplasm Staging ,Population Surveillance ,Prognosis ,Skin Neoplasms ,Survival Rate ,Time Factors - Abstract
PURPOSE: Although most hospital-based studies suggest more favorable survival with tumor-infiltrating lymphocytes (TILs) present in primary melanomas, it is uncertain whether TILs provide prognostic information beyond existing melanoma staging definitions. We addressed the issue in an international population-based study of patients with single and multiple primary melanomas. PATIENTS AND METHODS: On the basis of the Genes, Environment and Melanoma (GEM) study, we conducted follow-up of 2,845 patients diagnosed from 1998 to 2003 with 3,330 invasive primary melanomas centrally reviewed for TIL grade (absent, nonbrisk, or brisk). The odds of TIL grades associated with clinicopathologic features and survival by TIL grade were examined. RESULTS: Independent predictors (P < .05) for nonbrisk TIL grade were site, histologic subtype, and Breslow thickness, and for brisk TIL grade, they were age, site, Breslow thickness, and radial growth phase. Nonbrisk and brisk TIL grades were each associated with lower American Joint Committee on Cancer (AJCC) tumor stage compared with TIL absence (P(trend) < .001). Death as a result of melanoma was 30% less with nonbrisk TIL grade (hazard ratio [HR], 0.7; 95% CI, 0.5 to 1.0) and 50% less with brisk TIL grade (HR, 0.5; 95% CI, 0.3 to 0.9) relative to TIL absence, adjusted for age, sex, site, and AJCC tumor stage. CONCLUSION: At the population level, higher TIL grade of primary melanoma is associated with a lower risk of death as a result of melanoma independently of tumor characteristics currently used for AJCC tumor stage. We conclude that TIL grade deserves further prospective investigation to determine whether it should be included in future AJCC staging revisions.
- Published
- 2013
50. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.
- Author
-
Kricker, Anne, Armstrong, Bruce, Goumas, Chris, Thomas, Nancy, From, Lynn, Busam, Klaus, Kanetsky, Peter, Gallagher, Richard, Marrett, Loraine, Groben, Pamela, Gruber, Stephen, Rosso, Stefano, Dwyer, Terence, Berwick, Marianne, and Anton-Culver, Hoda
- Subjects
Adolescent ,Adult ,Aged ,Aged ,80 and over ,Child ,Female ,Follow-Up Studies ,Humans ,Male ,Melanoma ,Middle Aged ,Neoplasm Staging ,Neoplasms ,Multiple Primary ,Prognosis ,Proportional Hazards Models ,Registries ,Skin Neoplasms ,Survival Analysis ,Survival Rate ,Young Adult - Abstract
IMPORTANCE: Little is known about survival after a diagnosis of a second or higher-order (multiple) primary melanoma, and no study has explored survival in a population-based sample that included patients with single primary melanomas (SPMs) and multiple primary melanomas (MPMs) of any stage. Because people with a first primary melanoma are known to have an increased risk of being diagnosed with another, evidence for prognosis is needed. OBJECTIVE: To determine whether survival after diagnosis was better in patients with MPMs than with SPMs, as suggested in a recent study. DESIGN Survival analysis with median follow-up of 7.6 (range, 0.4-10.6) years. SETTING: The Genes, Environment, and Melanoma Study enrolled incident cases of melanoma from population-based cancer registries in Australia, Canada, Italy, and the United States. Multiple primary melanomas were ascertained during a longer period than SPM. PARTICIPANTS: Two thousand three hundred seventy-two patients with SPM and 1206 with MPM. EXPOSURE: Diagnosis with melanoma. MAIN OUTCOMES AND MEASURES: Melanoma-specific fatality hazard ratios (HR) and 95% confidence intervals associated with clinical and pathological characteristics of SPM, MPM, and both in Cox proportional hazards regression models. RESULTS: Melanoma thickness was the main determinant of fatality (HR for >4 mm, 7.68 [95% CI, 4.46-13.23]); other independent predictors were ulceration, mitoses, and scalp location. After adjustment for these other predictors, we found little difference in fatality between MPM and SPM (HR for MPM relative to SPM, 1.24 [95% CI, 0.91-1.69; P = .18]). Thicker SPM, however, had higher fatality (HR for >4 mm, 13.56 [95% CI, 6.47-28.40]) than thicker MPM (2.93 [1.17-7.30]). CONCLUSIONS AND RELEVANCE: Although overall fatalities due to SPM and MPM were similar, relative fatality for thicker SPM was greater than that for thicker MPM. This finding may offer support for a difference in outcome between patients with SPM and MPM related to factors other than closer surveillance and earlier diagnosis. The better outcomes are worth further exploration.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.